MedTrace Logo

Ubiquinone vs. Ubiquinol Supplementation

NCT06555575 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-04-10

No results posted yet for this study

Summary

The objective of this study is to determine if ubiquinol will result in improved reproductive outcomes in older women at a reduced oral dose compared to current standard treatment with ubiquinone.

Conditions

  • IVF

Interventions

DRUG

Ubiquinone 200 Mg Oral Capsule

By mouth three times daily for three months

DRUG

Ubiquinol 100 MG Oral Capsule

By mouth three times daily for three months

Sponsors & Collaborators

  • Trio Fertility

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
37 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-23
Primary Completion
2026-09-01
Completion
2027-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06555575 on ClinicalTrials.gov